Corp. SVP BioPharma Network

Corporate Vice President

Breakthroughs in IPF may lead to first approval in years

To Compete in Obesity, Late Entrants Invest Early in Manufacturing

TegMine Therapeutics Enters Collaboration with Boehringer Ingelheim to Advance Novel 2-Factor Antibody System for Cancer

Palatin Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim

Executive Director, ExpMED Oncology Immunotherapy

Boehringer Ingelheim is a global company focused on the discovery, development, and delivery of healthcare products. They are seeking an Executive Director for Experimental Medicine Oncology Immunotherapy to provide medical strategic leadership and oversee clinical development in this therapeutic area.

Executive Director, ExpMED Oncology Immunotherapy (Remote)

Vice President, Cancer Immunology & Immune Modulation

Chief Veterinary Officer

Associate Director, Oncology

Senior Associate Director, Medical Affairs

Executive Director, Human Pharma, Inspection Lifecycle Management

Sign up with Google

Sign in with Google